Recent molecular data revealed that, opposite to CML-BP, AML with BCR::ABL1 can be associated with NPM1 mutations while no ABL1 mutations have been described to date [3, 5]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.